LensGen
PrivateLast Round
Corporate Funding
Mar 2, 2023
Est. Valuation
$100M
Total Funding Raised
$41.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
LensGen operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Corporate Funding round in March 2023.
LensGen is an ophthalmic medical device company that has developed a biomimetic, fluid-optic intraocular lens for the treatment of cataracts and presbyopia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LensGen Comparables
Compare LensGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atia Vision | 93% | |
| Adaptilens | 90% | |
| JelliSee Ophthalmics Inc. | 89% |
For institutional investors. Book with your work email.
LensGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 2, 2023 | ||||
| Series B | Aug 20, 2020 | ||||
| Series A | May 1, 2017 |
For institutional investors. Book with your work email.
LensGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ExSight Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 304% MoM, reaching 3K.
- May 16, 2026
Monthly visitors grew 55% MoM, from 826 to 1.3K.
For institutional investors. Book with your work email.
LensGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LensGen's valuation, stock price, and market status.
Is LensGen a public or private company?
LensGen is a private company.
What is the current stock price of LensGen?
LensGen is a private company, so its shares have no public market price. Caplight tracks LensGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LensGen worth (valuation)?
LensGen's valuation is estimated at $100.0M based on funding round data.
Can I buy LensGen stock?
LensGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LensGen's last funding round?
LensGen's most recent funding round was Corporate Funding on March 2, 2023.
Who are the main investors in LensGen?
Key investors in LensGen include ExSight Ventures.
Will LensGen IPO soon?
No public IPO plans have been announced for LensGen.
How can I track LensGen secondary market activity?
Caplight tracks bids, offers, and trades in LensGen's shares on secondary markets.